Efficient Safety Review
Bring an industry-changing technology shift to the way signal safety data is collected, processed, and presented – freeing up safety scientists’ and risk physicians’ time to focus on other strategic objectives.
Automation of Causal Pathways
Automate causal pathways during signal screening or signal validation to add tremendous efficiency to serial case assessment time and enable a smaller and nimbler team to focus on the work that matters most
Standardize Safety Analytics
Standardize Safety Analytics across your physicians’ teams for better processing, saving time and costs, reducing risk, and providing a higher level of confidence in assessment and overall transparency.
Reduce Clinical Trial and Post-Marketing Costs
Enable significant cost savings by detecting potential safety signal issues earlier in clinical trials and post-market so that you can react faster and proactively minimize any potential downstream issues.
Connected Knowledge
Build an interconnected, causal thought model with links in medical history, medication, and events.
Case Tags
Create tags for case aggregates to increase collaboration on serial case assessments leading to faster and more robust case series assessments.
Association Graphs
Users can see automatic medical connections and can denote the strength of each association, increasing the ability to collaborate on serial case assessments.
Medical Clustering
Users can group cases based on medical similarities to help them better understand safety patterns and evaluate benefit-risk.
"*" indicates required fields
ArisGlobal is a pivotal partner in the life sciences industry, specializing in solutions that drive drug development, safety monitoring, and regulatory compliance. We collaborate with more than 500 global life sciences companies, CROs, and government health authorities, including leading biopharmaceutical firms and regulatory bodies such as FDA, Health Canada, and NMPA.
Headquartered in the United States, ArisGlobal has regional offices in Europe, India, Japan and China.
Quick Links
© 2024 ArisGlobal – All Rights Reserved